From: Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway
Variable | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95%CI | p-value | HR | 95%CI | p-value | |
Age (> 60/ ≤ 60) | 1.851 | 1.455–2.675 | 0.002* | 1.524 | 0.808–2.876 | 0.193 |
Gender (Female/Male) | 1.107 | 0.789–1.535 | 0.543 |  |  |  |
Grade (High/Low) | 2.867 | 0.709–11.588 | 0.139 |  |  |  |
Tumor depth (T3–T4/T0–T2) | 2.203 | 1.509–3.217 |  < 0.001* | 2.597 | 0.841–8.023 | 0.097 |
Lymph node (N1–N3/N0) | 2.359 | 1.723–3.230 |  < 0.001* | 1.711 | 0.972–3.012 | 0.063 |
Distant metastasis (M1/M0) | 3.306 | 1.580–6.917 | 0.002* | 1.63 | 0.615–4.325 | 0.326 |
Clinical stage (III + IV/I + II) | 2.288 | 1.573–3.328 |  < 0.001* | 1.51 | 0.443–5.146 | 0.51 |
ANXA1 (High/Low) | 1.973 | 1.455–2.675 |  < 0.001* | 2.34 | 1.403–3.909 | 0.001* |